TY - JOUR T1 - Fighting COVID-19 with Flexible Testing: Models and Insights JF - medRxiv DO - 10.1101/2020.11.17.20233577 SP - 2020.11.17.20233577 AU - Jiali Yu AU - Zuo-Jun (Max) Shen Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/18/2020.11.17.20233577.abstract N2 - Increasing testing capacities plays a substantial role in safely reopening the economy and avoiding a new wave of COVID-19. Pooled testing can expand testing capabilities by pooling multiple individual samples, but it also raises accuracy concerns. In this study, we propose a flexible testing strategy that adapts pool sizes to epidemic dynamics. We present an analytical method to calculate the optimal pool size and the prevalence threshold between individual and pooled testing. Incorporating an epidemic model, we show pooled testing is more effective in containing epidemic outbreaks and can generate more reliable test results than individual testing because the reliability of test results is relevant to both testing methods and prevalence. Our study is the first to evaluate the interplay between pooled testing and a rapidly evolving outbreak to the best of our knowledge. Our results allay accuracy concerns about pooled testing and provide theoretical supports to empirical studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere has been no significant financial support for this work that could have influenced its outcome.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Tsinghua UniversityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe use the testing data provided by the COVID Tracking Project who collects, cross-checks, and publishes COVID-19 testing data of the United States. To view more descriptions about data, please visit https://covidtracking.com/about-data. Johns Hopkins Coronavirus Resource Center provides a visualization tool for testing outcomes https://coronavirus.jhu.edu/testing/individual-states. The on-campus COVID-19 testing data dashboard of UIUC is available at https://go.illinois.edu/COVIDTestingData. All code is available for free use at https://github.com/JL-YU/Flexible-Testing. https://covidtracking.com/about-data https://coronavirus.jhu.edu/testing/individual-states https://go.illinois.edu/COVIDTestingData https://github.com/JL-YU/Flexible-Testing ER -